Patent Yard Sign in
Canadian application, no grantCanada

Human vanilloid receptor gene

CA 2428827 A1 · Owner: Masters, Jeffrey N. · Inventors: Masters, Jeffrey N.; Vos, Melissa H.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides an isolated or purified polynucleotide that encodes human vanilloid receptor. Isoforms of human vanilloid receptor are also disclosed. The invention also provides methods of making recombinant human vanilloid receptor using the polynucleotides and host cells transformed with the polynucleotides.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 10, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 10, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 10, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 10, 2000
GrantedNo grant recorded
Term endedNovember 10, 2020
Patent numberCA 2428827 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedNov 10, 2000Term endedNov 10, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.